March 10, 2023

The U.S. Food and Drug Administration (FDA) released a final rule updating the agency’s regulatory implementation of the Mammography Quality Standards Act Regulations of 1992 (MQSA). The American College of Radiology® (ACR®) is analyzing the final rule and will release further information for providers and accredited facilities once the review is complete.

The MQSA authorized the FDA to develop standards that would be enforced through strict accreditation, certification and inspection of equipment and personnel at mammography facilities. The ACR, via its Mammography Accreditation Program, is an FDA-approved accreditation body.

The FDA’s final rule makes several revisions to the program, including modifications related to repeated failure to achieve accreditation, breast density notification, record retention, equipment and quality control, and regulatory enforcement, among other issues. The rule goes into effect for mammography facilities Sept. 10, 2024.

Members with questions can contact Gloria Romanelli, JD, ACR Senior Director, Legislative and Regulatory Relations.


Related ACR News

  • State Legislative Bills Report

    As most state legislatures end their 2025 sessions and look to 2026, ACR staff is looking at how some radiology-specific bills they tracked fared this year.

    Read more
  • Medicare Payment Increase in Final Budget Reconciliation Bill

    The bill includes a 2.5% increase to the Medicare Physician Fee Schedule for calendar year 2026.

    Read more
  • CMS Announces Prior Authorization Test Model

    WiSer is a six-year program that will begin in six states on January 1, 2026. It will introduce prior authorization using AI technology for a select number of services, including some IR procedures.

    Read more